Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

NCT05617885 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Prostate Cancer

Interventions

DRUG: Darolutamide
DRUG: Abemaciclib
DRUG: GNRH-A Leuprolide Acetate
DRUG: GNRH-A Goserelin
DRUG: Degarelix

Sponsor

Praful Ravi, MB BCHir, MRCP

Collaborators

[object Object]
[object Object]